MPT0B291 treatment-mediated LINC00461 inhibition led to significantly elevated miR-485-3p expression (Fig. 6C) but it significantly reduced MELK expression in parental and TMZ-resistant GBM cells (Fig. 6D). This evidence concerns the gene MELK and glioblastoma.